Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by ttboy29on May 16, 2018 6:27pm
191 Views
Post# 28042403

Investor Relations - Contact them if you have concerns

Investor Relations - Contact them if you have concernsI emailed investor relations today and Mike Parmar called me back about 2 hours later. Don't be afraid to contact him through the investor inquiry link on the Isodiol site.

He was not evasive and we spoke for about 10 minutes.

I asked about ImmunAG - I sent  the direct link out earlier today that you could buy it. OOPS.

He told me they removed it from  the main site and that you cannot order it from the direct link i sent. They are awaiting the patent and are expect it soon so they can contiue to sell ImmunAG.

I asked him about Financials.

He told me they will be out July 31st and they will be audited Q4 and audited year end fiscal 2017.

I asked him if there was any chance that anyone (Joker) could have spoken with his brother Aman Parmar about the finacials being delayed. 

He laughed and said he had actually received a few calls about this and that his COUSIN Aman had not spoken to anyone about financial being delayed.

And then I asked him as a company why they felt the stock is under so much pressure with shorting and bashing.

He told me while they want the stock to be as high as possible on a day to day basis but like most stocks in the sector they have experienced a similar drop in share price. They are focussed on increasing revenues on a global scale and that there is so much going on that as revenues continue to increase the stock price will take care of itself. That is kind of a canned answer but what else could he say.

I told him to expect to hear from me again as i had more questions.

If you have questions you should direct them to him as well.

He will call you back and you can report back here to update the rest of us. I'd rather get info from the company itself as opposed to those shorting the stock.

GLTAL




Bullboard Posts